WELL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Welltower Inc (WELL) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong position in the senior housing market, consistent analyst upgrades, and positive long-term growth catalysts outweigh the short-term technical and financial challenges. The current pre-market dip of -0.21% offers a slightly better entry point.
The technical indicators are mixed but lean slightly bullish. The MACD is positive and contracting, suggesting potential upward momentum. RSI is neutral at 60.542, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading below the pivot level of 210.739, with key support at 206.877 and resistance at 214.601. Short-term downside risk exists, but long-term trends remain favorable.
Analysts have consistently raised price targets, with the latest targets ranging from $215 to $245, citing strong growth potential in the senior housing market and a 17% AFFO CAGR through
Hedge funds are significantly increasing their positions, with a 104.41% increase in buying activity last quarter.
Healthcare REITs are benefiting from aging demographics and limited supply, which align with Welltower's strategic focus.
Financial performance in 2025/Q3 showed a decline in net income (-37.63% YoY) and EPS (-43.84% YoY), despite a 30.65% revenue increase.
Short-term stock trend analysis indicates a 30% chance of a -1.69% drop in the next day and further declines over the next week and month.
No recent congress trading data or Intellectia Proprietary Trading Signals to provide additional confidence.
In 2025/Q3, Welltower's revenue increased by 30.65% YoY to $2.69 billion, indicating strong top-line growth. However, net income dropped by 37.63% YoY to $280.56 million, and EPS fell by 43.84% YoY to $0.41, reflecting margin pressures. Gross margin improved to 22.3%, up 4.40% YoY, showing operational efficiency improvements.
Analysts are overwhelmingly positive on Welltower, with multiple firms raising price targets and maintaining Buy or Overweight ratings. RBC, KeyBanc, and Citi highlight strong growth potential driven by aging demographics, portfolio restructuring, and tech investments. The lowest recent price target is $205, while the highest is $245, indicating significant upside potential from the current price of $208.01.
